Format

Send to

Choose Destination
J Comput Assist Tomogr. 2014 Jul-Aug;38(4):571-3. doi: 10.1097/RCT.0000000000000086.

The long-lasting effect of ferumoxytol on abdominal magnetic resonance imaging.

Author information

1
From the *Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI; and †Hematology & Oncology Associates of RI, Inc, Cranston, RI.

Abstract

Ferumoxytol is a parenteral iron therapy that the Food and Drug Administration recently approved for the treatment of iron-deficiency anemia. The form of the iron, ultrasmall superparamagnetic iron oxide nanoparticles, causes T1, T2, and T2* shortening on magnetic resonance imaging, which can mimic hemosiderosis. We report such a case, with laboratory findings that demonstrate normal iron stores, and discuss the potential implications.

PMID:
24733001
DOI:
10.1097/RCT.0000000000000086
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center